Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The TRIUMPH-1 Phase 3 clinical trial results, announced in May 2026, showcased participants losing up to 28.3% of their body weight over 80 weeks, indicating significant promise compared to other options like tirzepatide (Zepbound) and semaglutide (Wegovy)
Clinician evaluation
Benefits of LIPO-C / MIC-C Injections With regular use, patients often notice improvements in both physical and mental well-being
A sensitivity analysis excluding the ITCA trial yielded consistent results (HR (95%CI): 0.83 (0.750.93)
US$ 24.62
US$ 22.80
US$ 26.03
US$ 21.98
US$ 24.79
US$ 27.01
